Parkinson's Disease Stocks List

Parkinson's Disease Stocks Recent News

Date Stock Title
May 13 ACIU Sector Update: Health Care Stocks Mixed Late Afternoon
May 13 ACIU Top Midday Gainers
May 13 ACIU Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13 DNLI Denali Therapeutics: MPS Treatment Program Continues With End Of 2024 Data
May 13 ACIU Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
May 13 ACIU AC Immune rockets 47% on Alzheimer's therapy deal with Takeda
May 13 TEVA Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
May 13 ACIU Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
May 13 ACIU Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
May 13 ACIU AC Immune GAAP EPS of -$0.18 misses by $0.03
May 13 ACIU AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 13 ACIU AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
May 12 TEVA These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?
May 12 DNLI Cantor picks 14 undervalued biotech stocks worth a second look
May 11 DNLI The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
May 9 VTVT vTv Therapeutics GAAP EPS of -$1.17, revenue of $1M
May 9 VTVT vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 9 TEVA TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
May 9 TEVA Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
May 9 TEVA Affirm stock sinking, Good Buy or Goodbye: Market Domination
Parkinson's Disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

Browse All Tags